Follow the people · Insider
Robert E. Landry
Robert E. Landry files insider transactions with the SEC as a director of Cytokinetics.
- Files for 3 companiesCYTK, ZYME, REGN
- Disclosed buys and sellsstill being counted — the table below is complete
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 10 February 2025 — 11 September 2026Director · Cytokinetics 6 Form 4 lines · source: SEC Form 4
- Filed 11 August 2025 — 12 January 2026Director · Zymeworks 5 Form 4 lines · source: SEC Form 4
- Filed 9 September 2013 — 2 February 2024EVP Finance CFO · Regeneron Pharmaceuticals 520 Form 4 lines · source: SEC Form 4
Every transaction
the 400 most recent transactions from SEC Form 4 — one row each, sort any column, open a row for the filing; this is the most recent page of them| 11 Sep 2026 | 11 Sep 2026SEC Form 4 | 0 d | sold on the open market | Cytokinetics | 1,000 shares | up +0.0% | up +0.0% |
| 27 May 2026 | 27 May 2026SEC Form 4 | 0 d | was grantednot a trade | Cytokinetics | 2,851 shares | down −4.4% | down −4.4% |
| 27 May 2026 | 27 May 2026SEC Form 4 | 0 d | was grantednot a trade | Cytokineticsderivative | 4,301 shares | down −4.4% | down −4.4% |
| 12 Jan 2026 | 12 Jan 2026SEC Form 4 | 0 d | was grantednot a trade | Zymeworksderivative | 11,500 shares | up +13.3% | up +13.3% |
| 12 Jan 2026 | 12 Jan 2026SEC Form 4 | 0 d | was grantednot a trade | Zymeworksderivative | 7,700 shares | up +13.3% | up +13.3% |
| 12 Jan 2026 | 12 Jan 2026SEC Form 4 | 0 d | was grantednot a trade | Zymeworksderivative | 11,500 shares | up +13.3% | up +13.3% |
| 12 Jan 2026 | 12 Jan 2026SEC Form 4 | 0 d | was grantednot a trade | Zymeworksderivative | 7,700 shares | up +13.3% | up +13.3% |
| 11 Aug 2025 | 12 Aug 2025SEC Form 4 | 1 d | was grantednot a trade | Zymeworksderivative | 62,000 shares | up +110.9% | up +101.5% |
| 14 May 2025 | 14 May 2025SEC Form 4 | 0 d | was grantednot a trade | Cytokineticsderivative | 10,880 shares | up +145.9% | up +145.9% |
| 14 May 2025 | 14 May 2025SEC Form 4 | 0 d | was grantednot a trade | Cytokinetics | 7,333 shares | up +145.9% | up +145.9% |
| 10 Feb 2025 | 11 Feb 2025SEC Form 4 | 1 d | was grantednot a trade | Cytokineticsderivative | 25,538 shares | up +74.8% | up +77.5% |
| 8 Apr 2022 | 11 Apr 2022SEC Form 4 | 3 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 6,000 shares | up +5.8% | up +8.2% |
| 8 Apr 2022 | 11 Apr 2022SEC Form 4 | 3 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 2,000 shares | up +5.8% | up +8.2% |
| 8 Apr 2022 | 11 Apr 2022SEC Form 4 | 3 d | sold on the open market | Regeneron Pharmaceuticals | 16 shares | up +5.8% | up +8.2% |
| 8 Apr 2022 | 11 Apr 2022SEC Form 4 | 3 d | sold on the open market | Regeneron Pharmaceuticals | 30 shares | up +5.8% | up +8.2% |
| 7 Apr 2022 | 11 Apr 2022SEC Form 4 | 4 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 1,500 shares | up +8.3% | up +8.2% |
| 7 Apr 2022 | 11 Apr 2022SEC Form 4 | 4 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 1,500 shares | up +8.3% | up +8.2% |
| 7 Apr 2022 | 11 Apr 2022SEC Form 4 | 4 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,175 shares | up +8.3% | up +8.2% |
| 1 Apr 2022 | 1 Apr 2022SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 301 shares | up +12.5% | up +12.5% |
| 1 Apr 2022 | 1 Apr 2022SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 15 shares | up +12.5% | up +12.5% |
| 31 Mar 2022 | 1 Apr 2022SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 1,500 shares | up +11.9% | up +12.5% |
| 31 Mar 2022 | 1 Apr 2022SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 1,500 shares | up +11.9% | up +12.5% |
| 31 Mar 2022 | 1 Apr 2022SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,184 shares | up +11.9% | up +12.5% |
| 29 Mar 2022 | 30 Mar 2022SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 54 shares | up +11.9% | up +12.9% |
| 29 Mar 2022 | 30 Mar 2022SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 103 shares | up +11.9% | up +12.9% |
| 29 Mar 2022 | 30 Mar 2022SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 304 shares | up +11.9% | up +12.9% |
| 29 Mar 2022 | 30 Mar 2022SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 227 shares | up +11.9% | up +12.9% |
| 29 Mar 2022 | 30 Mar 2022SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 176 shares | up +11.9% | up +12.9% |
| 29 Mar 2022 | 30 Mar 2022SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 192 shares | up +11.9% | up +12.9% |
| 29 Mar 2022 | 30 Mar 2022SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 220 shares | up +11.9% | up +12.9% |
| 29 Mar 2022 | 30 Mar 2022SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 542 shares | up +11.9% | up +12.9% |
| 29 Mar 2022 | 30 Mar 2022SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 205 shares | up +11.9% | up +12.9% |
| 29 Mar 2022 | 30 Mar 2022SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 37 shares | up +11.9% | up +12.9% |
| 29 Mar 2022 | 30 Mar 2022SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 226 shares | up +11.9% | up +12.9% |
| 29 Mar 2022 | 30 Mar 2022SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 147 shares | up +11.9% | up +12.9% |
| 29 Mar 2022 | 30 Mar 2022SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 103 shares | up +11.9% | up +12.9% |
| 29 Mar 2022 | 30 Mar 2022SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 147 shares | up +11.9% | up +12.9% |
| 28 Mar 2022 | 30 Mar 2022SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 4,000 shares | up +12.7% | up +12.9% |
| 28 Mar 2022 | 30 Mar 2022SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 4,500 shares | up +12.7% | up +12.9% |
| 28 Mar 2022 | 30 Mar 2022SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 3,500 shares | up +12.7% | up +12.9% |
| 28 Mar 2022 | 30 Mar 2022SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 1,250 shares | up +12.7% | up +12.9% |
| 28 Mar 2022 | 30 Mar 2022SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 1,250 shares | up +12.7% | up +12.9% |
| 28 Mar 2022 | 30 Mar 2022SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 1,250 shares | up +12.7% | up +12.9% |
| 28 Mar 2022 | 30 Mar 2022SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,134 shares | up +12.7% | up +12.9% |
| 28 Mar 2022 | 30 Mar 2022SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 1,250 shares | up +12.7% | up +12.9% |
| 28 Mar 2022 | 30 Mar 2022SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,134 shares | up +12.7% | up +12.9% |
| 28 Mar 2022 | 30 Mar 2022SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 4,000 shares | up +12.7% | up +12.9% |
| 28 Mar 2022 | 30 Mar 2022SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 3,183 shares | up +12.7% | up +12.9% |
| 28 Mar 2022 | 30 Mar 2022SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 4,500 shares | up +12.7% | up +12.9% |
| 28 Mar 2022 | 30 Mar 2022SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 3,581 shares | up +12.7% | up +12.9% |
| 28 Mar 2022 | 30 Mar 2022SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 3,500 shares | up +12.7% | up +12.9% |
| 28 Mar 2022 | 30 Mar 2022SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 2,785 shares | up +12.7% | up +12.9% |
| 21 Mar 2022 | 23 Mar 2022SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 400 shares | up +12.7% | up +16.8% |
| 21 Mar 2022 | 23 Mar 2022SEC Form 4 | 2 d | sold on the open market | Regeneron Pharmaceuticals | 300 shares | up +12.7% | up +16.8% |
| 21 Mar 2022 | 23 Mar 2022SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 400 shares | up +12.7% | up +16.8% |
| 21 Mar 2022 | 23 Mar 2022SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 312 shares | up +12.7% | up +16.8% |
| 17 Mar 2022 | 18 Mar 2022SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 365 shares | up +14.0% | up +13.9% |
| 17 Mar 2022 | 18 Mar 2022SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 83 shares | up +14.0% | up +13.9% |
| 17 Mar 2022 | 18 Mar 2022SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 365 shares | up +14.0% | up +13.9% |
| 17 Mar 2022 | 18 Mar 2022SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 286 shares | up +14.0% | up +13.9% |
| 16 Mar 2022 | 18 Mar 2022SEC Form 4 | 2 d | sold on the open market | Regeneron Pharmaceuticals | 300 shares | up +15.3% | up +13.9% |
| 13 Dec 2021 | 14 Dec 2021SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 116 shares | up +18.4% | up +16.5% |
| 11 Dec 2021 | 14 Dec 2021SEC Form 4 | 3 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 697 shares | up +16.7% | up +16.5% |
| 10 Dec 2021 | 14 Dec 2021SEC Form 4 | 4 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 1,500 shares | up +16.7% | up +16.5% |
| 10 Dec 2021 | 14 Dec 2021SEC Form 4 | 4 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 1,500 shares | up +16.7% | up +16.5% |
| 10 Dec 2021 | 14 Dec 2021SEC Form 4 | 4 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,384 shares | up +16.7% | up +16.5% |
| 10 Dec 2021 | 10 Dec 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 2 shares | up +16.7% | up +16.7% |
| 10 Dec 2021 | 10 Dec 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 50 shares | up +16.7% | up +16.7% |
| 10 Dec 2021 | 10 Dec 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 11 shares | up +16.7% | up +16.7% |
| 10 Dec 2021 | 10 Dec 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 4 shares | up +16.7% | up +16.7% |
| 10 Dec 2021 | 10 Dec 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 25 shares | up +16.7% | up +16.7% |
| 10 Dec 2021 | 10 Dec 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 123 shares | up +16.7% | up +16.7% |
| 10 Dec 2021 | 10 Dec 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 19 shares | up +16.7% | up +16.7% |
| 10 Dec 2021 | 10 Dec 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 15 shares | up +16.7% | up +16.7% |
| 10 Dec 2021 | 10 Dec 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 18 shares | up +16.7% | up +16.7% |
| 10 Dec 2021 | 10 Dec 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 68 shares | up +16.7% | up +16.7% |
| 10 Dec 2021 | 10 Dec 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 7 shares | up +16.7% | up +16.7% |
| 10 Dec 2021 | 10 Dec 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 178 shares | up +16.7% | up +16.7% |
| 10 Dec 2021 | 10 Dec 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 130 shares | up +16.7% | up +16.7% |
| 10 Dec 2021 | 10 Dec 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 58 shares | up +16.7% | up +16.7% |
| 10 Dec 2021 | 10 Dec 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 14 shares | up +16.7% | up +16.7% |
| 10 Dec 2021 | 10 Dec 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 59 shares | up +16.7% | up +16.7% |
| 9 Dec 2021 | 10 Dec 2021SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 4,250 shares | up +17.4% | up +16.7% |
| 9 Dec 2021 | 10 Dec 2021SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 4,250 shares | up +17.4% | up +16.7% |
| 9 Dec 2021 | 10 Dec 2021SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 3,469 shares | up +17.4% | up +16.7% |
| 8 Dec 2021 | 10 Dec 2021SEC Form 4 | 2 d | was grantednot a trade | Regeneron Pharmaceuticalsderivative | 16,958 shares | up +19.5% | up +16.7% |
| 8 Dec 2021 | 10 Dec 2021SEC Form 4 | 2 d | was grantednot a trade | Regeneron Pharmaceuticals | 3,971 shares | up +19.5% | up +16.7% |
| 17 Nov 2021 | 18 Nov 2021SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 681 shares | up +21.8% | up +20.5% |
| 16 Nov 2021 | 18 Nov 2021SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 3,750 shares | up +21.6% | up +20.5% |
| 16 Nov 2021 | 18 Nov 2021SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 3,750 shares | up +21.6% | up +20.5% |
| 16 Nov 2021 | 18 Nov 2021SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 3,069 shares | up +21.6% | up +20.5% |
| 31 Aug 2021 | 1 Sep 2021SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 1,000 shares | up +16.1% | up +14.8% |
| 31 Aug 2021 | 1 Sep 2021SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 1,000 shares | up +16.1% | up +14.8% |
| 31 Aug 2021 | 1 Sep 2021SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 917 shares | up +16.1% | up +14.8% |
| 10 Aug 2021 | 10 Aug 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 433 shares | up +27.1% | up +27.1% |
| 10 Aug 2021 | 10 Aug 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 50 shares | up +27.1% | up +27.1% |
| 10 Aug 2021 | 10 Aug 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 1 share | up +27.1% | up +27.1% |
| 10 Aug 2021 | 10 Aug 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 1 share | up +27.1% | up +27.1% |
| 10 Aug 2021 | 10 Aug 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 45 shares | up +27.1% | up +27.1% |
| 10 Aug 2021 | 10 Aug 2021SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 7 shares | up +27.1% | up +27.1% |
| 9 Aug 2021 | 10 Aug 2021SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 1 share | up +27.3% | up +27.1% |
| 9 Aug 2021 | 10 Aug 2021SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 36 shares | up +27.3% | up +27.1% |
| 9 Aug 2021 | 10 Aug 2021SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 1 share | up +27.3% | up +27.1% |
| 9 Aug 2021 | 10 Aug 2021SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 66 shares | up +27.3% | up +27.1% |
| 9 Aug 2021 | 10 Aug 2021SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 40 shares | up +27.3% | up +27.1% |
| 9 Aug 2021 | 10 Aug 2021SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 36 shares | up +27.3% | up +27.1% |
| 9 Aug 2021 | 10 Aug 2021SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 58 shares | up +27.3% | up +27.1% |
| 9 Aug 2021 | 10 Aug 2021SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 36 shares | up +27.3% | up +27.1% |
| 9 Aug 2021 | 10 Aug 2021SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 54 shares | up +27.3% | up +27.1% |
| 9 Aug 2021 | 10 Aug 2021SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 36 shares | up +27.3% | up +27.1% |
| 9 Aug 2021 | 10 Aug 2021SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 3,000 shares | up +27.3% | up +27.1% |
| 9 Aug 2021 | 10 Aug 2021SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 2,463 shares | up +27.3% | up +27.1% |
| 9 Aug 2021 | 10 Aug 2021SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 3,000 shares | up +27.3% | up +27.1% |
| 6 Aug 2021 | 10 Aug 2021SEC Form 4 | 4 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 2,000 shares | up +27.9% | up +27.1% |
| 6 Aug 2021 | 10 Aug 2021SEC Form 4 | 4 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,636 shares | up +27.9% | up +27.1% |
| 6 Aug 2021 | 10 Aug 2021SEC Form 4 | 4 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 2,000 shares | up +27.9% | up +27.1% |
| 9 Dec 2020 | 11 Dec 2020SEC Form 4 | 2 d | was grantednot a trade | Regeneron Pharmaceuticalsderivative | 19,950 shares | up +59.9% | up +62.9% |
| 9 Dec 2020 | 11 Dec 2020SEC Form 4 | 2 d | was grantednot a trade | Regeneron Pharmaceuticals | 1,930 shares | up +59.9% | up +62.9% |
| 4 Aug 2020 | 5 Aug 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 696 shares | up +20.5% | up +25.1% |
| 21 Jul 2020 | 22 Jul 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 388 shares | up +22.3% | up +22.6% |
| 21 Jul 2020 | 22 Jul 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 3 shares | up +22.3% | up +22.6% |
| 20 Jul 2020 | 22 Jul 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 3,500 shares | up +18.7% | up +22.6% |
| 20 Jul 2020 | 22 Jul 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 5,000 shares | up +18.7% | up +22.6% |
| 20 Jul 2020 | 22 Jul 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 3,500 shares | up +18.7% | up +22.6% |
| 20 Jul 2020 | 22 Jul 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 2,802 shares | up +18.7% | up +22.6% |
| 20 Jul 2020 | 22 Jul 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 5,000 shares | up +18.7% | up +22.6% |
| 20 Jul 2020 | 22 Jul 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 4,611 shares | up +18.7% | up +22.6% |
| 14 Jul 2020 | 14 Jul 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 579 shares | up +21.9% | up +21.9% |
| 9 Jul 2020 | 13 Jul 2020SEC Form 4 | 4 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 3,000 shares | up +22.0% | up +26.9% |
| 9 Jul 2020 | 13 Jul 2020SEC Form 4 | 4 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 3,000 shares | up +22.0% | up +26.9% |
| 9 Jul 2020 | 13 Jul 2020SEC Form 4 | 4 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 2,421 shares | up +22.0% | up +26.9% |
| 8 Jul 2020 | 9 Jul 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 24 shares | up +22.0% | up +22.0% |
| 8 Jul 2020 | 9 Jul 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 585 shares | up +22.0% | up +22.0% |
| 8 Jul 2020 | 9 Jul 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 40 shares | up +22.0% | up +22.0% |
| 8 Jul 2020 | 9 Jul 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 45 shares | up +22.0% | up +22.0% |
| 8 Jul 2020 | 9 Jul 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 80 shares | up +22.0% | up +22.0% |
| 8 Jul 2020 | 9 Jul 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 43 shares | up +22.0% | up +22.0% |
| 8 Jul 2020 | 9 Jul 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 48 shares | up +22.0% | up +22.0% |
| 8 Jul 2020 | 9 Jul 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 104 shares | up +22.0% | up +22.0% |
| 8 Jul 2020 | 9 Jul 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 57 shares | up +22.0% | up +22.0% |
| 8 Jul 2020 | 9 Jul 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 37 shares | up +22.0% | up +22.0% |
| 8 Jul 2020 | 9 Jul 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 94 shares | up +22.0% | up +22.0% |
| 8 Jul 2020 | 9 Jul 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 3 shares | up +22.0% | up +22.0% |
| 7 Jul 2020 | 9 Jul 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 2,500 shares | up +21.9% | up +22.0% |
| 7 Jul 2020 | 9 Jul 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 10,000 shares | up +21.9% | up +22.0% |
| 7 Jul 2020 | 9 Jul 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 10,000 shares | up +21.9% | up +22.0% |
| 7 Jul 2020 | 9 Jul 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 9,321 shares | up +21.9% | up +22.0% |
| 7 Jul 2020 | 9 Jul 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 2,500 shares | up +21.9% | up +22.0% |
| 7 Jul 2020 | 9 Jul 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 2,019 shares | up +21.9% | up +22.0% |
| 29 Jun 2020 | 30 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 39 shares | up +27.9% | up +25.3% |
| 29 Jun 2020 | 30 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 58 shares | up +27.9% | up +25.3% |
| 29 Jun 2020 | 30 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 50 shares | up +27.9% | up +25.3% |
| 29 Jun 2020 | 30 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 153 shares | up +27.9% | up +25.3% |
| 29 Jun 2020 | 30 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 69 shares | up +27.9% | up +25.3% |
| 29 Jun 2020 | 30 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 31 shares | up +27.9% | up +25.3% |
| 23 Jun 2020 | 24 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 40 shares | up +24.3% | up +29.2% |
| 23 Jun 2020 | 24 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 56 shares | up +24.3% | up +29.2% |
| 23 Jun 2020 | 24 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 39 shares | up +24.3% | up +29.2% |
| 23 Jun 2020 | 24 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 82 shares | up +24.3% | up +29.2% |
| 23 Jun 2020 | 24 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 78 shares | up +24.3% | up +29.2% |
| 23 Jun 2020 | 24 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 82 shares | up +24.3% | up +29.2% |
| 23 Jun 2020 | 24 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 89 shares | up +24.3% | up +29.2% |
| 23 Jun 2020 | 24 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 46 shares | up +24.3% | up +29.2% |
| 22 Jun 2020 | 24 Jun 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 8,900 shares | up +24.3% | up +29.2% |
| 22 Jun 2020 | 24 Jun 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 8,900 shares | up +24.3% | up +29.2% |
| 22 Jun 2020 | 24 Jun 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 8,388 shares | up +24.3% | up +29.2% |
| 11 Jun 2020 | 12 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 445 shares | up +31.1% | up +32.8% |
| 11 Jun 2020 | 12 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 65 shares | up +31.1% | up +32.8% |
| 11 Jun 2020 | 12 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 14 shares | up +31.1% | up +32.8% |
| 11 Jun 2020 | 12 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 177 shares | up +31.1% | up +32.8% |
| 11 Jun 2020 | 12 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 23 shares | up +31.1% | up +32.8% |
| 11 Jun 2020 | 12 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 34 shares | up +31.1% | up +32.8% |
| 11 Jun 2020 | 12 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 31 shares | up +31.1% | up +32.8% |
| 11 Jun 2020 | 12 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 66 shares | up +31.1% | up +32.8% |
| 11 Jun 2020 | 12 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 58 shares | up +31.1% | up +32.8% |
| 11 Jun 2020 | 12 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 16 shares | up +31.1% | up +32.8% |
| 11 Jun 2020 | 12 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 59 shares | up +31.1% | up +32.8% |
| 10 Jun 2020 | 12 Jun 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 3,500 shares | up +28.8% | up +32.8% |
| 10 Jun 2020 | 12 Jun 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 3,500 shares | up +28.8% | up +32.8% |
| 10 Jun 2020 | 12 Jun 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 2,512 shares | up +28.8% | up +32.8% |
| 9 Jun 2020 | 10 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 110 shares | up +28.4% | up +28.8% |
| 9 Jun 2020 | 10 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 131 shares | up +28.4% | up +28.8% |
| 9 Jun 2020 | 10 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 50 shares | up +28.4% | up +28.8% |
| 9 Jun 2020 | 10 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 289 shares | up +28.4% | up +28.8% |
| 9 Jun 2020 | 10 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 353 shares | up +28.4% | up +28.8% |
| 9 Jun 2020 | 10 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 619 shares | up +28.4% | up +28.8% |
| 9 Jun 2020 | 10 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 1,511 shares | up +28.4% | up +28.8% |
| 9 Jun 2020 | 10 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 681 shares | up +28.4% | up +28.8% |
| 9 Jun 2020 | 10 Jun 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 527 shares | up +28.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 3,500 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 3,500 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 2,500 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 2,250 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 2,250 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 1,500 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 3,500 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 2,536 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 3,500 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 2,536 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 2,500 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,811 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 2,250 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,630 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 2,250 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,630 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 1,500 shares | up +29.4% | up +28.8% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,086 shares | up +29.4% | up +28.8% |
| 20 Apr 2020 | 20 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 35 shares | up +37.6% | up +37.6% |
| 20 Apr 2020 | 20 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 225 shares | up +37.6% | up +37.6% |
| 20 Apr 2020 | 20 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 340 shares | up +37.6% | up +37.6% |
| 20 Apr 2020 | 20 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 902 shares | up +37.6% | up +37.6% |
| 20 Apr 2020 | 20 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 944 shares | up +37.6% | up +37.6% |
| 20 Apr 2020 | 20 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 114 shares | up +37.6% | up +37.6% |
| 20 Apr 2020 | 20 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 126 shares | up +37.6% | up +37.6% |
| 20 Apr 2020 | 20 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 66 shares | up +37.6% | up +37.6% |
| 20 Apr 2020 | 20 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 114 shares | up +37.6% | up +37.6% |
| 20 Apr 2020 | 20 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 64 shares | up +37.6% | up +37.6% |
| 20 Apr 2020 | 20 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 320 shares | up +37.6% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | sold on the open market | Regeneron Pharmaceuticals | 33 shares | up +37.4% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | sold on the open market | Regeneron Pharmaceuticals | 33 shares | up +37.4% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | sold on the open market | Regeneron Pharmaceuticals | 61 shares | up +37.4% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | sold on the open market | Regeneron Pharmaceuticals | 3 shares | up +37.4% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | sold on the open market | Regeneron Pharmaceuticals | 55 shares | up +37.4% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | sold on the open market | Regeneron Pharmaceuticals | 62 shares | up +37.4% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | sold on the open market | Regeneron Pharmaceuticals | 33 shares | up +37.4% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | sold on the open market | Regeneron Pharmaceuticals | 89 shares | up +37.4% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | sold on the open market | Regeneron Pharmaceuticals | 155 shares | up +37.4% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | sold on the open market | Regeneron Pharmaceuticals | 232 shares | up +37.4% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | sold on the open market | Regeneron Pharmaceuticals | 92 shares | up +37.4% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | sold on the open market | Regeneron Pharmaceuticals | 33 shares | up +37.4% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | sold on the open market | Regeneron Pharmaceuticals | 66 shares | up +37.4% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | sold on the open market | Regeneron Pharmaceuticals | 44 shares | up +37.4% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 12,500 shares | up +37.4% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 9,250 shares | up +37.4% | up +37.6% |
| 17 Apr 2020 | 20 Apr 2020SEC Form 4 | 3 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 12,500 shares | up +37.4% | up +37.6% |
| 16 Apr 2020 | 20 Apr 2020SEC Form 4 | 4 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 4,000 shares | up +44.7% | up +37.6% |
| 16 Apr 2020 | 20 Apr 2020SEC Form 4 | 4 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 3,009 shares | up +44.7% | up +37.6% |
| 16 Apr 2020 | 20 Apr 2020SEC Form 4 | 4 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 4,000 shares | up +44.7% | up +37.6% |
| 15 Apr 2020 | 16 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 54 shares | up +52.7% | up +44.7% |
| 15 Apr 2020 | 16 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 304 shares | up +52.7% | up +44.7% |
| 15 Apr 2020 | 16 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 287 shares | up +52.7% | up +44.7% |
| 15 Apr 2020 | 16 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 76 shares | up +52.7% | up +44.7% |
| 15 Apr 2020 | 16 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 130 shares | up +52.7% | up +44.7% |
| 15 Apr 2020 | 16 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 2 shares | up +52.7% | up +44.7% |
| 14 Apr 2020 | 16 Apr 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 3,500 shares | up +48.9% | up +44.7% |
| 14 Apr 2020 | 16 Apr 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 3,500 shares | up +48.9% | up +44.7% |
| 14 Apr 2020 | 16 Apr 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 2,647 shares | up +48.9% | up +44.7% |
| 13 Apr 2020 | 13 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 99 shares | up +51.2% | up +51.2% |
| 13 Apr 2020 | 13 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 38 shares | up +51.2% | up +51.2% |
| 13 Apr 2020 | 13 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 30 shares | up +51.2% | up +51.2% |
| 13 Apr 2020 | 13 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 115 shares | up +51.2% | up +51.2% |
| 13 Apr 2020 | 13 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 170 shares | up +51.2% | up +51.2% |
| 13 Apr 2020 | 13 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 143 shares | up +51.2% | up +51.2% |
| 13 Apr 2020 | 13 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 156 shares | up +51.2% | up +51.2% |
| 13 Apr 2020 | 13 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 31 shares | up +51.2% | up +51.2% |
| 13 Apr 2020 | 13 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 46 shares | up +51.2% | up +51.2% |
| 9 Apr 2020 | 13 Apr 2020SEC Form 4 | 4 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 3,500 shares | up +52.3% | up +51.2% |
| 9 Apr 2020 | 13 Apr 2020SEC Form 4 | 4 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 3,500 shares | up +52.3% | up +51.2% |
| 9 Apr 2020 | 13 Apr 2020SEC Form 4 | 4 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 2,672 shares | up +52.3% | up +51.2% |
| 7 Apr 2020 | 8 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 694 shares | up +55.8% | up +52.5% |
| 7 Apr 2020 | 8 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 2 shares | up +55.8% | up +52.5% |
| 6 Apr 2020 | 8 Apr 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 3,000 shares | up +55.0% | up +52.5% |
| 6 Apr 2020 | 8 Apr 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 2,304 shares | up +55.0% | up +52.5% |
| 6 Apr 2020 | 8 Apr 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 3,000 shares | up +55.0% | up +52.5% |
| 3 Apr 2020 | 3 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 121 shares | up +58.4% | up +58.4% |
| 3 Apr 2020 | 3 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 50 shares | up +58.4% | up +58.4% |
| 3 Apr 2020 | 3 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 25 shares | up +58.4% | up +58.4% |
| 3 Apr 2020 | 3 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 99 shares | up +58.4% | up +58.4% |
| 3 Apr 2020 | 3 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 172 shares | up +58.4% | up +58.4% |
| 3 Apr 2020 | 3 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 2 shares | up +58.4% | up +58.4% |
| 3 Apr 2020 | 3 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 54 shares | up +58.4% | up +58.4% |
| 3 Apr 2020 | 3 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 25 shares | up +58.4% | up +58.4% |
| 3 Apr 2020 | 3 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 62 shares | up +58.4% | up +58.4% |
| 3 Apr 2020 | 3 Apr 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 73 shares | up +58.4% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 3,000 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 2,317 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 139 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 22 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 62 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 78 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 91 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 246 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 128 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 51 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 85 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 109 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 146 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 91 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 3,000 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 69 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 11 shares | up +56.7% | up +58.4% |
| 2 Apr 2020 | 3 Apr 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 25 shares | up +56.7% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | sold on the open market | Regeneron Pharmaceuticals | 23 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | sold on the open market | Regeneron Pharmaceuticals | 75 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | sold on the open market | Regeneron Pharmaceuticals | 87 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | sold on the open market | Regeneron Pharmaceuticals | 1 share | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | sold on the open market | Regeneron Pharmaceuticals | 23 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | sold on the open market | Regeneron Pharmaceuticals | 23 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | sold on the open market | Regeneron Pharmaceuticals | 61 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | sold on the open market | Regeneron Pharmaceuticals | 87 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | sold on the open market | Regeneron Pharmaceuticals | 64 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | sold on the open market | Regeneron Pharmaceuticals | 156 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 2,500 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,936 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 2,000 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,549 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 1,500 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,162 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 2,500 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 2,000 shares | up +57.4% | up +58.4% |
| 1 Apr 2020 | 3 Apr 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 1,500 shares | up +57.4% | up +58.4% |
| 26 Feb 2020 | 26 Feb 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 10 shares | up +70.7% | up +70.7% |
| 26 Feb 2020 | 26 Feb 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 44 shares | up +70.7% | up +70.7% |
| 26 Feb 2020 | 26 Feb 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 18 shares | up +70.7% | up +70.7% |
| 26 Feb 2020 | 26 Feb 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 32 shares | up +70.7% | up +70.7% |
| 26 Feb 2020 | 26 Feb 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 10 shares | up +70.7% | up +70.7% |
| 26 Feb 2020 | 26 Feb 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 25 shares | up +70.7% | up +70.7% |
| 26 Feb 2020 | 26 Feb 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 27 shares | up +70.7% | up +70.7% |
| 26 Feb 2020 | 26 Feb 2020SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 34 shares | up +70.7% | up +70.7% |
| 25 Feb 2020 | 26 Feb 2020SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 1,000 shares | up +76.7% | up +70.7% |
| 25 Feb 2020 | 26 Feb 2020SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 1,000 shares | up +76.7% | up +70.7% |
| 25 Feb 2020 | 26 Feb 2020SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 800 shares | up +76.7% | up +70.7% |
| 25 Feb 2020 | 26 Feb 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 10 shares | up +76.7% | up +70.7% |
| 25 Feb 2020 | 26 Feb 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 12 shares | up +76.7% | up +70.7% |
| 25 Feb 2020 | 26 Feb 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 11 shares | up +76.7% | up +70.7% |
| 25 Feb 2020 | 26 Feb 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 37 shares | up +76.7% | up +70.7% |
| 25 Feb 2020 | 26 Feb 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 18 shares | up +76.7% | up +70.7% |
| 25 Feb 2020 | 26 Feb 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 54 shares | up +76.7% | up +70.7% |
| 25 Feb 2020 | 26 Feb 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 35 shares | up +76.7% | up +70.7% |
| 25 Feb 2020 | 26 Feb 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 16 shares | up +76.7% | up +70.7% |
| 25 Feb 2020 | 26 Feb 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 4 shares | up +76.7% | up +70.7% |
| 25 Feb 2020 | 26 Feb 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 17 shares | up +76.7% | up +70.7% |
| 24 Feb 2020 | 26 Feb 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 1,000 shares | up +83.7% | up +70.7% |
| 24 Feb 2020 | 26 Feb 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 1,000 shares | up +83.7% | up +70.7% |
| 24 Feb 2020 | 26 Feb 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 786 shares | up +83.7% | up +70.7% |
| 13 Feb 2020 | 14 Feb 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 47 shares | up +96.0% | up +95.6% |
| 13 Feb 2020 | 14 Feb 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 22 shares | up +96.0% | up +95.6% |
| 13 Feb 2020 | 14 Feb 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 21 shares | up +96.0% | up +95.6% |
| 13 Feb 2020 | 14 Feb 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 8 shares | up +96.0% | up +95.6% |
| 13 Feb 2020 | 14 Feb 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 4 shares | up +96.0% | up +95.6% |
| 13 Feb 2020 | 14 Feb 2020SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 5 shares | up +96.0% | up +95.6% |
| 12 Feb 2020 | 14 Feb 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 500 shares | up +92.3% | up +95.6% |
| 12 Feb 2020 | 14 Feb 2020SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 500 shares | up +92.3% | up +95.6% |
| 12 Feb 2020 | 14 Feb 2020SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 393 shares | up +92.3% | up +95.6% |
| 11 Dec 2019 | 13 Dec 2019SEC Form 4 | 2 d | was grantednot a trade | Regeneron Pharmaceuticalsderivative | 24,500 shares | up +109.2% | up +107.6% |
| 11 Dec 2019 | 13 Dec 2019SEC Form 4 | 2 d | was grantednot a trade | Regeneron Pharmaceuticals | 2,625 shares | up +109.2% | up +107.6% |
| 11 Dec 2019 | 13 Dec 2019SEC Form 4 | 2 d | was grantednot a trade | Regeneron Pharmaceuticals | 5,000 shares | up +109.2% | up +107.6% |
| 12 Dec 2018 | 14 Dec 2018SEC Form 4 | 2 d | was grantednot a trade | Regeneron Pharmaceuticals | 12,500 shares | up +106.8% | up +105.0% |
| 12 Dec 2018 | 14 Dec 2018SEC Form 4 | 2 d | was grantednot a trade | Regeneron Pharmaceuticalsderivative | 20,000 shares | up +106.8% | up +105.0% |
| 10 Sep 2018 | 11 Sep 2018SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 2,251 shares | up +97.8% | up +98.5% |
| 12 Dec 2017 | 13 Dec 2017SEC Form 4 | 1 d | was grantednot a trade | Regeneron Pharmaceuticalsderivative | 23,337 shares | up +104.7% | up +102.1% |
| 6 Sep 2017 | 6 Sep 2017SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 100 shares | up +56.2% | up +56.2% |
| 6 Sep 2017 | 6 Sep 2017SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 74 shares | up +56.2% | up +56.2% |
| 6 Sep 2017 | 6 Sep 2017SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 100 shares | up +56.2% | up +56.2% |
| 6 Sep 2017 | 6 Sep 2017SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 100 shares | up +56.2% | up +56.2% |
| 6 Sep 2017 | 6 Sep 2017SEC Form 4 | 0 d | sold on the open market | Regeneron Pharmaceuticals | 100 shares | up +56.2% | up +56.2% |
| 5 Sep 2017 | 6 Sep 2017SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 100 shares | up +58.1% | up +56.2% |
| 5 Sep 2017 | 6 Sep 2017SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 89 shares | up +58.1% | up +56.2% |
| 1 Sep 2017 | 6 Sep 2017SEC Form 4 | 5 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 3,000 shares | up +55.1% | up +56.2% |
| 1 Sep 2017 | 6 Sep 2017SEC Form 4 | 5 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,631 shares | up +55.1% | up +56.2% |
| 1 Sep 2017 | 6 Sep 2017SEC Form 4 | 5 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 706 shares | up +55.1% | up +56.2% |
| 1 Sep 2017 | 6 Sep 2017SEC Form 4 | 5 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 3,000 shares | up +55.1% | up +56.2% |
| 31 Aug 2017 | 1 Sep 2017SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 100 shares | up +57.3% | up +55.1% |
| 31 Aug 2017 | 1 Sep 2017SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 100 shares | up +57.3% | up +55.1% |
| 31 Aug 2017 | 1 Sep 2017SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 100 shares | up +57.3% | up +55.1% |
| 31 Aug 2017 | 1 Sep 2017SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 127 shares | up +57.3% | up +55.1% |
| 30 Aug 2017 | 1 Sep 2017SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 2,000 shares | up +60.4% | up +55.1% |
| 30 Aug 2017 | 1 Sep 2017SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,119 shares | up +60.4% | up +55.1% |
| 30 Aug 2017 | 1 Sep 2017SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 454 shares | up +60.4% | up +55.1% |
| 30 Aug 2017 | 1 Sep 2017SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 2,000 shares | up +60.4% | up +55.1% |
| 23 Aug 2017 | 24 Aug 2017SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 100 shares | up +63.8% | up +61.0% |
| 23 Aug 2017 | 24 Aug 2017SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 100 shares | up +63.8% | up +61.0% |
| 23 Aug 2017 | 24 Aug 2017SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 168 shares | up +63.8% | up +61.0% |
| 23 Aug 2017 | 24 Aug 2017SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 100 shares | up +63.8% | up +61.0% |
| 22 Aug 2017 | 24 Aug 2017SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 2,000 shares | up +63.3% | up +61.0% |
| 22 Aug 2017 | 24 Aug 2017SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,144 shares | up +63.3% | up +61.0% |
| 22 Aug 2017 | 24 Aug 2017SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 388 shares | up +63.3% | up +61.0% |
| 22 Aug 2017 | 24 Aug 2017SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 2,000 shares | up +63.3% | up +61.0% |
| 8 Aug 2017 | 9 Aug 2017SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 100 shares | up +66.4% | up +64.8% |
| 8 Aug 2017 | 9 Aug 2017SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 100 shares | up +66.4% | up +64.8% |
| 8 Aug 2017 | 9 Aug 2017SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 100 shares | up +66.4% | up +64.8% |
| 8 Aug 2017 | 9 Aug 2017SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 226 shares | up +66.4% | up +64.8% |
| 7 Aug 2017 | 9 Aug 2017SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 2,000 shares | up +66.2% | up +64.8% |
| 7 Aug 2017 | 9 Aug 2017SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,167 shares | up +66.2% | up +64.8% |
| 7 Aug 2017 | 9 Aug 2017SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 307 shares | up +66.2% | up +64.8% |
| 7 Aug 2017 | 9 Aug 2017SEC Form 4 | 2 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 2,000 shares | up +66.2% | up +64.8% |
| 16 Dec 2016 | 19 Dec 2016SEC Form 4 | 3 d | was grantednot a trade | Regeneron Pharmaceuticalsderivative | 24,565 shares | up +106.3% | up +110.2% |
| 16 Dec 2015 | 18 Dec 2015SEC Form 4 | 2 d | was grantednot a trade | Regeneron Pharmaceuticalsderivative | 28,900 shares | up +39.6% | up +43.6% |
| 5 Aug 2015 | 6 Aug 2015SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 4,000 shares | up +31.9% | up +34.2% |
| 5 Aug 2015 | 6 Aug 2015SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 400 shares | up +31.9% | up +34.2% |
| 5 Aug 2015 | 6 Aug 2015SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 1,500 shares | up +31.9% | up +34.2% |
| 5 Aug 2015 | 6 Aug 2015SEC Form 4 | 1 d | sold on the open market | Regeneron Pharmaceuticals | 2,100 shares | up +31.9% | up +34.2% |
| 5 Aug 2015 | 6 Aug 2015SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 4,000 shares | up +31.9% | up +34.2% |
| 8 Apr 2015 | 9 Apr 2015SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticals | 10,000 shares | up +72.4% | up +71.7% |
| 8 Apr 2015 | 9 Apr 2015SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 6,066 shares | up +72.4% | up +71.7% |
| 8 Apr 2015 | 9 Apr 2015SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Regeneron Pharmaceuticals | 1,835 shares | up +72.4% | up +71.7% |
| 8 Apr 2015 | 9 Apr 2015SEC Form 4 | 1 d | exercised options overnot a trade | Regeneron Pharmaceuticalsderivative | 10,000 shares | up +72.4% | up +71.7% |
| 16 Dec 2014 | 18 Dec 2014SEC Form 4 | 2 d | was grantednot a trade | Regeneron Pharmaceuticalsderivative | 34,000 shares | up +97.3% | up +84.4% |
| 9 Sep 2013 | 11 Sep 2013SEC Form 4 | 2 d | was grantednot a trade | Regeneron Pharmaceuticalsderivative | 80,000 shares | up +182.3% | up +182.3% |
| 9 Sep 2013 | 11 Sep 2013SEC Form 4 | 2 d | was grantednot a trade | Regeneron Pharmaceuticals | 5,000 shares | up +182.3% | up +182.3% |
Both percentages are the stock’s move, not Robert E. Landry’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 400 of the 400 rows shown carry a percentage; the rest are dashes with the reason on the row.
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.
Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.